Haematology

Uzm. Dr. Bülent Kantarcıoğlu

Doctor and researcher Sancaktepe Şehit Prof. Dr. İlhan Varank Eğitim ve Araştırma Hastanesi İstanbul
Pulmonary EmbolismCOVID-19Atrial FibrillationThrombosisKidney Failure, Chronic
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Pulmonary Embolism 9 publications
    Source: OpenAlex / PubMed MeSHView publications
  • COVID-19 4 publications
  • Atrial Fibrillation 3 publications
  • Thrombosis 3 publications
  • Kidney Failure, Chronic 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologysaglik.gov.trFrom source
  • InstitutionSancaktepe Şehit Prof. Dr. İlhan Varank Eğitim ve Araştırma Hastanesisaglik.gov.trFrom source
  • Area of workPulmonary EmbolismExtracted from 9 publications · Model version —From source
  • Publications65 publicationsEurope PMC, OpenAlexFrom source
  • ORCID0000-0003-3060-721XORCIDFrom source
  • Last synchronised5 November 2026 08:56https://sancaktepeah.saglik.gov.tr/TR-1488452/doktorlarimiz.html#bulent-kantarcioglusaglik.gov.tr

Scientific work

Publications on Pulmonary Embolism

65 publications

  1. The Role of Circulating MicroRNAs as Biomarkers and Therapeutic Targets in Venous Thromboembolism: A Systematic Review

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15166306 PMID 42652709 Open-access full textSource: Europe PMC

  2. Multifactorial thrombotic risk in Evans syndrome: a case report and review of the literature

    Thrombosis journal, 2026

    DOI 10.1186/s12959-026-00846-9 PMID 41736014 Open-access full textSource: Europe PMC

  3. Circulating Exosomal MicroRNAs as Potential Biomarkers for Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2026

    DOI 10.1177/10760296251407689 PMID 41773945 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  4. Thromboinflammation and hemostatic activation drive early mortality risk in pulmonary embolism

    Research and Practice in Thrombosis and Haemostasis, 2026

    DOI 10.1016/j.rpth.2026.106633 PMID 42293734 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. PB2552 Cytokine-Driven and Immune-Inflammatory Signatures Predicts Early Mortality in Acute Pulmonary Embolism

    Research and Practice in Thrombosis and Haemostasis, 2026

    DOI 10.1016/j.rpth.2026.105292 Open-access full textSource: OpenAlex

  6. Plasminogen Activator Inhibitor-1 and Mean Platelet Volume as Potential Indicators of Prothrombotic State in Immune Thrombocytopenia: An Exploratory Study

    Medical Sciences, 2026

    DOI 10.3390/medsci14070712 Open-access full textSource: OpenAlex

  7. Decreased Thrombin Generation is Associated with Increased Thrombin Generation Biomarkers and Blood Cellular Indices in Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241261076 PMID 39043231 Open-access full textSource: Europe PMC

  8. Charlson and Elixhauser Comorbidity Indices for Prediction of Mortality and Hospital Readmission in Patients With Acute Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241253844 PMID 38755956 6 citations (Europe PMC) Open-access full textSource: Europe PMC

  9. Endogenous Dysregulation of Thromboinflammatory Biomarkers in End-Stage Renal Disease, and Their Amplification by Heart Failure

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241263858 PMID 39140866 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  10. Vascular Endothelial Dysfunction and Immunothrombosis in the Pathogenesis of Atrial Fibrillation

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241296138 PMID 39654486 6 citations (Europe PMC) Open-access full textSource: Europe PMC

View all 65 publications